Loading...
XASXNGS
Market cap3mUSD
Dec 23, Last price  
0.05AUD
1D
0.00%
1Q
45.16%
IPO
-98.33%
Name

Nutritional Growth Solutions Ltd

Chart & Performance

D1W1MN
XASX:NGS chart
P/E
P/S
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
172.18%
Rev. gr., 5y
44.98%
Revenues
0k
-100.00%
701,7891,703,7411,870,0003,040,0002,947,0000
Net income
0k
P
-58,928-2,922,550-4,361,000-4,780,000-4,249,0000
CFO
0k
P
392,412-2,591,586-2,277,633-5,084,119-6,971,6980

Profile

Nutritional Growth Solutions Ltd. develops, produces, and sells pediatric protein supplements in the United States and internationally. It offers its products under the Horlicks, Healthy Height, and Pro Up brand names. The company was formerly known as N. G. Solutions Ltd. and changed its name to Nutritional Growth Solutions Ltd. in June 2020. The company was incorporated in 2013 and is based in Tel Aviv, Israel.
IPO date
Oct 30, 2020
Employees
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
2,947
-3.06%
3,040
62.57%
Cost of revenue
7,291
7,773
Unusual Expense (Income)
NOPBT
(4,344)
(4,733)
NOPBT Margin
Operating Taxes
(227)
(147)
Tax Rate
NOPAT
(4,117)
(4,586)
Net income
(4,249)
-11.11%
(4,780)
9.61%
Dividends
Dividend yield
Proceeds from repurchase of equity
696
2,244
3,425
BB yield
-25.79%
-2.88%
-1.80%
Debt
Debt current
351
37
36
Long-term debt
33
37
110
Deferred revenue
Other long-term liabilities
Net debt
212
(1,447)
(3,996)
Cash flow
Cash from operating activities
(6,972)
(5,084)
CAPEX
(4)
(79)
Cash from investing activities
(4)
(87)
Cash from financing activities
998
2,208
3,415
FCF
524
(4,588)
(4,653)
Balance
Cash
172
1,521
4,142
Long term investments
Excess cash
172
1,374
3,990
Stockholders' equity
(177)
2,075
3,875
Invested Capital
362
738
73
ROIC
ROCE
EV
Common stock shares outstanding
19,277
129,724
102,591
Price
0.14
-76.67%
0.60
-67.57%
1.85
-28.85%
Market cap
2,699
-96.53%
77,835
-58.99%
189,793
-22.93%
EV
2,911
76,388
185,797
EBITDA
(4,256)
(4,586)
EV/EBITDA
Interest
18
65
Interest/NOPBT